<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">55911</article-id><article-id pub-id-type="doi">10.7554/eLife.55911</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-182681"><name><surname>Kovalenko</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182682"><name><surname>Erdin</surname><given-names>Serkan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6587-2625</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182683"><name><surname>Andrew</surname><given-names>Marissa A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182687"><name><surname>St Claire</surname><given-names>Jason</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182688"><name><surname>Shaughnessey</surname><given-names>Melissa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182689"><name><surname>Hubert</surname><given-names>Leroy</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182690"><name><surname>Neto</surname><given-names>João Luís</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0863-158X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182704"><name><surname>Stortchevoi</surname><given-names>Alexei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-67523"><name><surname>Fass</surname><given-names>Daniel M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0018-8093</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-182692"><name><surname>Mouro Pinto</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-126262"><name><surname>Haggarty</surname><given-names>Stephen J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7872-168X</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-175235"><name><surname>Wilson</surname><given-names>John H</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182694"><name><surname>Talkowski</surname><given-names>Michael E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-125739"><name><surname>Wheeler</surname><given-names>Vanessa C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2619-589X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><institution content-type="dept">Center for Genomic Medicine</institution>, <institution>Massachusetts General Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Center for Genomic Medicine/Program in Medical and Population Genetics</institution>, <institution>Massachusetts General Hospital/Broad Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Center for Genomic Medicine; Department of Neurology</institution>, <institution>Massachusetts General Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Verna and Marrs McLean Department of Biochemistry and Molecular Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Chemical Neurobiology Laboratory</institution>, <institution>Massachusetts General Hospital, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-3452"><name><surname>Orr</surname><given-names>Harry T</given-names></name><role>Reviewing editor</role><aff><institution>University of Minnesota</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>wheeler@helix.mgh.harvard.edu</email> (VW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>09</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e55911</elocation-id><history><date date-type="received"><day>10</day><month>02</month><year>2020</year></date><date date-type="accepted"><day>28</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Kovalenko et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Kovalenko et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-55911-v1.pdf"/><abstract><p>Somatic expansion of the Huntington's disease (HD) CAG repeat drives the rate of a pathogenic process ultimately resulting in neuronal cell death. Although mechanisms of toxicity are poorly delineated, transcriptional dysregulation is a likely contributor. To identify modifiers that act at the level of CAG expansion and/or downstream pathogenic processes, we tested the impact of genetic knockout, in <italic>Htt</italic><sup>Q111</sup> mice, of <italic>Hdac2</italic> or <italic>Hdac3</italic> in medium-spiny striatal neurons that exhibit extensive CAG expansion and exquisite disease vulnerability. Both knockouts moderately attenuated CAG expansion, with <italic>Hdac2</italic> knockout decreasing nuclear huntingtin pathology. <italic>Hdac2</italic> knockout resulted in a substantial transcriptional response that included modification of transcriptional dysregulation elicited by the <italic>Htt</italic><sup>Q111</sup> allele, likely via mechanisms unrelated to instability suppression. Our results identify novel modifiers of different aspects of HD pathogenesis in MSNs and highlight a complex relationship between the expanded <italic>Htt</italic> allele and <italic>Hdac2</italic> with implications for targeting transcriptional dysregulation in HD.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009836</institution-id><institution>Huntington Society of Canada</institution></institution-wrap></funding-source><award-id>New Pathways Research Grant</award-id><principal-award-recipient><name><surname>Wheeler</surname><given-names>Vanessa C</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NS049206</award-id><principal-award-recipient><name><surname>Wheeler</surname><given-names>Vanessa C</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000887</institution-id><institution>Huntington's Disease Society of America</institution></institution-wrap></funding-source><award-id>Berman Topper Career Development Award</award-id><principal-award-recipient><name><surname>Mouro Pinto</surname><given-names>Ricardo</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM38219</award-id><principal-award-recipient><name><surname>Wilson</surname><given-names>John H</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>EY11731</award-id><principal-award-recipient><name><surname>Wilson</surname><given-names>John H</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1F3HG004918</award-id><principal-award-recipient><name><surname>Hubert</surname><given-names>Leroy</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Daniel M Fass, D.M.F. is a member of the scientific advisory board of Psy Therapeutics..</p></fn><fn fn-type="conflict" id="conf3"><p>Stephen J Haggarty, S.J.H. is a member of the scientific advisory board of Psy Therapeutics, Frequency Therapeutics and Souvien Therapeutics, and former member of the scientific advisory board of Rodin Therapeutics that is focused on HDAC2 inhibitors, none of whom were involved in the present study. S.J.H. has also received speaking or consulting fees from Amgen, AstraZeneca, Biogen, Merck, Regenacy Pharmaceuticals, as well as sponsored research or gift funding from AstraZeneca, JW Pharmaceuticals, and Vesigen unrelated to the content of this manuscript. His financial interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies..</p></fn><fn fn-type="conflict" id="conf4"><p>Vanessa C Wheeler, V.C.W is a scientific advisory board member of Triplet Therapeutics, a company developing new therapeutic approaches to address triplet repeat disorders such Huntington's disease and Myotonic Dystrophy and of LoQus23 Therapeutics. Her financial interests in Triplet Therapeutics, were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health under an approved protocol (2009N000216) of the Massachusetts General Hospital Subcommittee on Research Animal Care.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>RNA-Seq data is deposited in GEO, under the accession number GSE148440</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kovalenko M</collab><collab>Erdin S</collab><collab>Andrew MA</collab><collab>St Claire J</collab><collab>Shaughnessey M</collab><collab>Hubert L</collab><collab>Neto JL</collab><collab>Stortchevoi A</collab><collab>Fass DM</collab><collab>Pinto RM</collab><collab>Haggarty SJ</collab><collab>Wilson JH</collab><collab>Talkowski ME</collab><collab>Wheeler VC</collab></person-group><year iso-8601-date="2020">2020</year><source>Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE148440">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE148440</ext-link><comment>NCBI Gene Expression Omnibus, GSE148440</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-55911-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>